Leaders | Meritocracy with Chinese characteristics

For Xi Jinping, loyalty trumps ability

China’s president has assembled a top team of yes-men

TOPSHOT - China's President Xi Jinping (L) walks with (2nd L to R) Li Qiang, Li Xi, Zhao Leji, Ding Xuexiang, Wang Huning and Cai Qi, members of the Chinese Communist Party's new Politburo Standing Committee, the nation's top decision-making body, as they meet the media in the Great Hall of the People in Beijing on October 23, 2022. (Photo by WANG Zhao / AFP) (Photo by WANG ZHAO/AFP via Getty Images)

The day after President Xi Jinping was granted a precedent-trampling third term as chief of the Communist Party on October 23rd, state media had nothing but praise for him. China was embarking on a “new journey”, said the papers, one “full of glory and dreams”. Alas, the journey has got off to a rough start. On October 24th global financial markets were full of worry and disappointment. Foreign investors dumped China’s shares and its currency.

This article appeared in the Leaders section of the print edition under the headline “Team of loyalists”

Will Iran’s women win?

From the October 29th 2022 edition

Discover stories from this section and more in the list of contents

Explore the edition

More from Leaders

Keir Starmer surrounded by the Eu stars

Sir Keir Starmer should aim higher in his reset with the EU

And he needs to be clearer about what Britain wants

illustration of a world map outlined by a single red electrical cord, with a plug at one end and a socket at the other

To make electricity cheaper and greener, connect the world’s grids

Less than 3% of the world’s power is internationally traded—a huge wasted opportunity


Chinese AI is catching up, posing a dilemma for Donald Trump

The success of cheap Chinese models threatens America’s technological lead


America has an imperial presidency

And in Donald Trump, an imperialist president for the first time in over a century

Tariffs will harm America, not induce a manufacturing rebirth

Donald Trump’s pursuit of tariffs will make the world poorer—and America, too 

How to improve clinical trials

Involving more participants can lead to new medical insights